Dendreon's Provenge Therapeutic Cancer Vaccine Has A May 15 PDUFA Date
The prostate cancer immunotherapeutic is the first therapeutic cancer vaccine accepted for review by FDA.
The prostate cancer immunotherapeutic is the first therapeutic cancer vaccine accepted for review by FDA.